Sam Brusco, Associate Editor09.11.23
Philips has released a super resolution, contrast-enhanced (CEUS) ultrasound application for its EPIQ Elite ultrasound system.
The current standard of care to assess lesion blood flow requires intravenous injection of an iodinated contrast media not well tolerated by certain patients. In these instances, contrast-enhanced ultrasound (CEUS) is quickly becoming a viable alternative as an increasingly important tool for lesion characterization.
Rather than an iodinated contrast media, CEUS uses micro-bubble contrast media based on an inert gas excreted via the patient’s breathing. Philips said its Microvascular Imaging (MVI) Super Resolution CEUS offers up to 200% better spatial resolution than previous offerings.
“Philips’ microvascular imaging allows us to visualize the pattern of contrast media flow into a lesion, and also shows how it changes over time, which gives us greater diagnostic confidence in assessing indeterminate lesions,” Professor Dirk-André Clevert, Professor of Radiology at Ludwig-Maximilians-Universität (LMU), Munich, Germany, told the press. “Sharing our knowledge about how to use this latest technology and interpret the results has been greatly enhanced by Philips’ latest Collaboration Live software, which allows us to remotely train external sonographers and guide them through procedures.”
Super resolution MVI doesn’t expose patients to ionizing radiation, and Philips said it’s generally more cost-effective and accessible. The company also said compared to iodinated contrast media, adverse reactions to the micro-bubble contrast media used in CEUS is lower.
Philips’ EPIQ Elite ultrasound features a range of multiple diagnostic applications and tools to meet the needs of specific medical specialties.
The current standard of care to assess lesion blood flow requires intravenous injection of an iodinated contrast media not well tolerated by certain patients. In these instances, contrast-enhanced ultrasound (CEUS) is quickly becoming a viable alternative as an increasingly important tool for lesion characterization.
Rather than an iodinated contrast media, CEUS uses micro-bubble contrast media based on an inert gas excreted via the patient’s breathing. Philips said its Microvascular Imaging (MVI) Super Resolution CEUS offers up to 200% better spatial resolution than previous offerings.
“Philips’ microvascular imaging allows us to visualize the pattern of contrast media flow into a lesion, and also shows how it changes over time, which gives us greater diagnostic confidence in assessing indeterminate lesions,” Professor Dirk-André Clevert, Professor of Radiology at Ludwig-Maximilians-Universität (LMU), Munich, Germany, told the press. “Sharing our knowledge about how to use this latest technology and interpret the results has been greatly enhanced by Philips’ latest Collaboration Live software, which allows us to remotely train external sonographers and guide them through procedures.”
Super resolution MVI doesn’t expose patients to ionizing radiation, and Philips said it’s generally more cost-effective and accessible. The company also said compared to iodinated contrast media, adverse reactions to the micro-bubble contrast media used in CEUS is lower.
Philips’ EPIQ Elite ultrasound features a range of multiple diagnostic applications and tools to meet the needs of specific medical specialties.